Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

242 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer.
Sanz Del Olmo N, Bajo AM, Ionov M, García-Gallego S, Bryszewska M, Gómez R, Ortega P, de la Mata FJ. Sanz Del Olmo N, et al. Among authors: Ortega P. Eur J Med Chem. 2020 May 8;199:112414. doi: 10.1016/j.ejmech.2020.112414. Online ahead of print. Eur J Med Chem. 2020. PMID: 32438200
Cationic Carbosilane Dendritic Systems as Promising Anti-Amyloid Agents in Type 2 Diabetes.
Lozano-Cruz T, Alcarraz-Vizán G, de la Mata FJ, de Pablo S, Ortega P, Duarte Y, Bravo-Moraga F, González-Nilo FD, Novials A, Gómez R. Lozano-Cruz T, et al. Among authors: Ortega P. Chemistry. 2020 Apr 7. doi: 10.1002/chem.202000091. Online ahead of print. Chemistry. 2020. PMID: 32259327
Histone deacetylases facilitate the accurate repair of broken forks.
Gómez-González B, Ortega P, Aguilera A. Gómez-González B, et al. Among authors: Ortega P. Mol Cell Oncol. 2020 Jan 13;7(2):1705731. doi: 10.1080/23723556.2019.1705731. eCollection 2020. Mol Cell Oncol. 2020. PMID: 32158920
In Reply to Schmuter.
Ortega P. Ortega P. Acad Med. 2020 Feb;95(2):172. doi: 10.1097/ACM.0000000000003082. Acad Med. 2020. PMID: 31990717 No abstract available.
242 results
Jump to page